Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY ISSUE OF SEPTEMBER 08, 2006 FBO #1747
SOLICITATION NOTICE

B -- Promoter Hypermethyaltion in the Argentine Bladder Cancer Tumor Marker Study

Notice Date
9/6/2006
 
Notice Type
Solicitation Notice
 
NAICS
541380 — Testing Laboratories
 
Contracting Office
Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 6120 Executive Blvd. EPS Suite 600, Rockville, MD, 20852
 
ZIP Code
20852
 
Solicitation Number
NCI-60169-NG
 
Response Due
9/15/2006
 
Archive Date
9/30/2006
 
Small Business Set-Aside
Total Small Business
 
Description
The National Cancer Institute, Division of Cancer Epidemiology and Genetics (DCEG), plans to procure on a sole source basis services regarding Promoter Hypermethyaltion in the Argentine Bladder Cancer Tumor Marker Study with Transgenomic Inc., 12325 Emmet Street, Omaha, Nebraska 68164. The supplies and services herein are being procured in accordance with FAR Part 12 with the authority to use simplified acquisition procedures as authorized by FAR Part 13. The North American Industry Classification System code is 541380 and the business size standard is $11M. This acquisition is set aside for a Total Small Business. The purpose of this requisition is to analyze promoter hypermethylation status in DNA from 28 cases that were exposed to varied levels of arsenic in drinking water. CpG sites within the promoter region of ten genes will be analyzed to determine whether each promoter is hypermethylated and potentially silenced by exposure to arsenic in drinking water. Transgenomic, Inc. conducted the pilot study using samples from the Argentina Case-control study MQ515301. They developed novel methods to bisulfite treat and sequence all CpG sites in the promoter region and are to our knowledge the only laboratory using this method. Therefore, because of comparability of these results to those of the previous pilot study with these unique methods developed, Transgenomic Inc. is the only source to conduct the analysis of these samples. This notice is not a request for competitive quotation. However, if any interested party believes it can meet the above requirement, it may submit a statement of capabilities. The statement of capabilities and any other information furnished must be in writing and must contain material in sufficient detail to allow NCI to determine if the party can perform the requirement. Capability statements must be received in the contracting office by 1:00 PM EDT, on September 15, 2006. For further information please contact Malinda Holdcraft, Contract Specialist via electronic mail at holdcram@exchange.nih.gov. A determination by the Government not to compete this proposed requirement based upon responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. No collect calls will be accepted. No faxed or emailed capability statements will be accepted. In order to receive an award, contractors must be registered in the Central Contractor Registration (CCR) and the Online Representations and Certifications Applications (ORCA). Reference NCI-60196-NG.
 
Place of Performance
Address: Contractor Location
Zip Code: 68164
Country: UNITED STATES
 
Record
SN01134709-W 20060908/060906220358 (fbodaily.com)
 
Source
FedBizOpps Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.